Zhai D

No ORCID on file · 5 papers in corpus
other 2021
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06057-z

Endometriosis (EM) in reproductive females has an incidence of 6-10% and greatly affects female fertility, quality of life, and long-term health. The gut microbiota can affect the physiological and pathological processes of humans through v…

2018
OncoTargets and therapy ·doi:10.2147/ott.s162985

BackgroundOvarian adenosquamous carcinoma is an extremely rare type of ovarian histology. Platinum-refractory disease is also uncommon, but can be fatal because of the lack of available treatment options. To date, there is no study or case …

article 2015
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2015/269138

Objective. To explore the effects of puerarin to treat endometriosis (EMT) model rats and the possible regulatory mechanisms. Methods. EMT model rats were surgically induced by autotransplantion of endometrial tissues. The appropriate dosag…

article 2013
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2013.07.006

Background and objectivesPuerarin, a phytoestrogen with a weak estrogenic effect, binds to estrogen receptors, thereby competing with 17β-estradiol and producing an anti-estrogenic effect. In our early clinical practice to treat endometrios…

article 2012
PloS one ·doi:10.1371/journal.pone.0045529

BACKGROUND: Puerarin is a major isoflavonoid compound extracted from Radix puerariae. It has a weak estrogenic action by binding to estrogen receptors (ERs). In our early clinical practice to treat endometriosis, a better therapeutic effect…